HIROYUKI TADA: Open Payments
NPI 1710346895 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 44 payments from 13 companies in 2025. Trend: 2023 $1,323 · 2024 $1,118 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $163 |
| Janssen Pharmaceuticals, Inc | 6 | $136 |
| SANOFI-AVENTIS U.S. LLC | 5 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Lilly USA, LLC | 4 | $72 |
| Exact Sciences Corporation | 4 | $62 |
| Globus Medical, Inc. | 1 | $30 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $23 |
Products named: SPRAVATO, Ozempic, TZIELD, REXULTI, MOUNJARO, Wegovy, Cologuard Collection Kit, Senza.
Industry payments across GA — which companies pay providers there.
